# Otsuka Holdings to acquire remaining shares of ReCor Medical

Otsuka Holdings Co., Ltd. announced a merger agreement to acquire the remaining shares of ReCor Medical, Inc. The transaction is subject to ReCor's shareholder approval.

- Type: Acquisition
- Announced: 2019-12-11
- Where: United States
- Status: announced
- Products: Paradise Renal Denervation System
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Otsuka Holdings](https://endata.com/companies/33020.md) (acquirer)
- [ReCor Medical](https://endata.com/companies/33021.md) (target)
- [Otsuka Medical Devices](https://endata.com/companies/33022.md) (partner)

## Sources

- [openminds.com](https://openminds.com/market-intelligence/bulletins/otsuka-medical-devices-otsuka-holdings-recor-medical-announce-signing-of-merger-agreement/), 2019-12-11: "Otsuka Holdings' acquisition follows the announcement by ReCor on June 15, 2018 that the U.S. Food and Drug Administration has given its approval to initiate a pivotal clinical study, RADIANCE II, for the evaluation of the Paradise® Renal Denervation System for safe and effective reduction of blood "

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.